Industry

Hevolution Commits $8.5 Million to Support Junior Investigators in Multi-Year Grant Program with AFAR RIYADH, Saudi Arabia–(BUSINESS WIRE)–#aging—Hevolution Foundation, a non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, and the American Federation for Aging Research (AFAR) announce an international research grant program to enable early-career investigators to … [Read more…]

Amit Ahluwalia joins Lively from Lumity, as Lively increases revenue 6x year-over-year SAN FRANCISCO–(BUSINESS WIRE)–#hsa—Lively, Inc., the HSA provider that gets it right, today announces it has hired Amit Ahluwalia as its Chief Revenue Officer (CRO). This announcement comes with recent company growth milestones, including 6x year-over year growth as Lively prepares for healthcare open … [Read more…]

CS-2 Sets Another Record: The Only Single System Capable of Training Transformer-Style NLP Models with 20x Longer Sequences SUNNYVALE, Calif.–(BUSINESS WIRE)–#AI—Cerebras Systems, the pioneer in accelerating artificial intelligence (AI) compute, released yet another industry-first capability today. Customers can now rapidly train Transformer-style natural language AI models with 20x longer sequences than is possible using traditional … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–#nasal–A newly published Random Clinical Trial (RCT) provides additional support for statements Xlear made about the use of nasal hygiene as an added layer of protection in combatting the SARS-CoV-2 virus. The Federal Trade Commission (FTC) has sued Xlear concerning prior statements. Most importantly, the new RCT pilot study found no anosmia … [Read more…]

NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that company management will participate in a fireside chat at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 3:10 p.m. ET … [Read more…]

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in Citi’s 17th Annual BioPharma Conference taking place September 7-8 in Boston, Massachusetts. Yuri Maricich, MD, Chief Medical Officer, will participate in a panel discussion on Mental Health at 10:30 … [Read more…]

ROOT, Switzerland–(BUSINESS WIRE)–$NVCR–Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor conferences. William Doyle, Executive Chairman, and Ashley Cordova, Chief Financial Officer, will participate in the 2022 Wells Fargo Healthcare Conference on September 7, 2022. Mr. Doyle and Ms. Cordova will take part in a fireside chat at 4:20 p.m. EDT, … [Read more…]

Also Available, in Limited Market Release, Is Masimo W1 with Hydration Index, Designed to Provide Insight Into an Individual’s Hydration IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the full market release of the Masimo W1™ health watch for consumer use. The first of its kind, the Masimo W1 offers accurate, continuous measurements and insightful health … [Read more…]

Dalrada Health’s Sòlas Rejuvenation + Wellness Clinics Partner With San Diego Strike Force IFL and San Diego Loyal Soccer Pro Team to Promote Community Wellness SAN DIEGO–(BUSINESS WIRE)–Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada Corporation,” “Dalrada”), a leading innovator in clean energy, healthcare, technology, and precision manufacturing, announced today the expansion of its wellness services to … [Read more…]

The trial is designed to evaluate the candidate’s safety, tolerability, and immunogenicity NEW YORK–(BUSINESS WIRE)–#OutsmartEpidemics–IAVI, a nonprofit scientific research organization, announces that volunteers at the PREVAIL clinical trial site at Redemption Hospital (RH1) in Monrovia, Liberia, have been vaccinated with IAVI’s novel vaccine candidate against Lassa fever virus (LASV) in a Phase I clinical trial, … [Read more…]